Newborn antibodies to SARS-CoV-2 detected in cord blood after maternal vaccination - a case report
- PMID: 33752624
- PMCID: PMC7982334
- DOI: 10.1186/s12887-021-02618-y
Newborn antibodies to SARS-CoV-2 detected in cord blood after maternal vaccination - a case report
Abstract
Background: Maternal vaccination for Influenza and Tetanus, Diphtheria, acellular Pertussis (TDaP) have been well studied in terms of safety and efficacy for protection of the newborn by placental passage of antibodies. Similar newborn protection would be expected after maternal vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for coronavirus disease 2019 (COVID-19). There is a significant and urgent need for research regarding safety and efficacy of vaccination against SARS-CoV-2 during pregnancy.
Case presentation: A vigorous, healthy, full-term female was born to a COVID-19 naïve mother who had received a single dose of messenger RNA (mRNA) vaccine for SARS-CoV-2 3 weeks prior to delivery. IgG cord blood antibodies were detected to SARS-CoV-2 at the time of birth.
Conclusion: Here, we report the first known case of an infant with SARS-CoV-2 IgG antibodies detectable in cord blood after maternal vaccination.
Keywords: COVID-19; Cord blood; Maternal; Newborn; Vaccination.
Conflict of interest statement
The authors have competing interests to disclose.
References
-
- Woo PC, Lau SK, Wong BH, et al. Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked Immunosorbent assay (ELISA) and SARS coronavirus Nucleocapsid protein ELISA for Serodiagnosis of SARS coronavirus pneumonia. J Clin Microbiol. 2005;43(7):3054–3058. doi: 10.1128/JCM.43.7.3054-3058.2005. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous